In vivo and in vitro experiments with DS and ferrostatin-1 (Fer-1) demonstrate promising results in preventing cardiomyocyte ferroptosis post-MI by evaluating ferroptosis-related indicators, Nrf2 signaling, and myocardial damage, potentially enhancing therapeutic strategies for cardiovascular diseases.
Collection
[
|
...
]